Circulating Tumor HPV DNA Testing for HPV-Positive Head and Neck Cancer

NavDx Optimizing HPV+ Cancer SurveillanceПодробнее

Key Insights on Screening for HPV-Positive Oropharynx CancerПодробнее

What do you tell patients about HPV Infection Risks and testing with Liquid Biopsy? Dr. Mihir PatelПодробнее

Case Study: Monitoring Treatment Response - Dr. Mihir BhayaniПодробнее

Clinical Application of NavDx in the PreTreatment Setting and During Treatment - Dr. Glenn HannaПодробнее

Clinical Application of NavDx in the Surveillance Setting (5min) - Dr. Glenn HannaПодробнее

The future of liquid biopsies in head and neck cancerПодробнее

AHNS 11th International Head and Neck Cancer Conference, July 8-12, 2023Подробнее

NavDx Optimizing HPV+ Cancer Surveillance for PatientsПодробнее

Case Study: Identifying Molecular Residual Disease - Dr. Glenn HannaПодробнее

Guest Lecture : "Emerging Insights on the Genetic Map of Head-Neck Cancer and Impact Cancer Care"Подробнее

Oncotarget: New HPV Assay to Predict HNSCC Treatment ResponseПодробнее

AHNS Webinar Series: Molecular Diagnostics & Surveillance in HPV-Associated Oropharyngeal CancerПодробнее

Head and Neck Cancer Management in North Carolina Updates for 2020 - S. Sheth - 20200422Подробнее

Clinical Trial Update in HPV Associated Oropharynx Cancer B Chera 20191023Подробнее

Advancing the care and management of patients with HPV driven head and neck cancers.Подробнее

Case Study: Identifying Recurrence After Surgical Resection - Dr. Abie MendelsohnПодробнее

Demystifying Molecular-Based Tests in Head and Neck Cancers - S. Sheth - 20220928Подробнее

Circulating Tumor (CT) and HPV DNA - ASCO Recaps Head and Neck Cancer Patient EducationПодробнее